BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 6832205)

  • 1. Non-linear elimination processes of theophylline.
    Gundert-Remy U; Hildebrandt R; Hengen N; Weber E
    Eur J Clin Pharmacol; 1983; 24(1):71-8. PubMed ID: 6832205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose dependent pharmacokinetics of theophylline: Michaelis-Menten parameters for its major metabolic pathways.
    Dadashzadeh S; Tajerzaden H
    Eur J Drug Metab Pharmacokinet; 2001; 26(1-2):77-83. PubMed ID: 11554438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonlinear metabolic disposition of theophylline.
    Dahlqvist R; Billing B; Miners JO; Birkett DJ
    Ther Drug Monit; 1984; 6(3):290-7. PubMed ID: 6506136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonlinear theophylline elimination.
    Tang-Liu DD; Williams RL; Riegelman S
    Clin Pharmacol Ther; 1982 Mar; 31(3):358-69. PubMed ID: 7060318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of methylxanthine-containing foods on theophylline metabolism and kinetics.
    Monks TJ; Caldwell J; Smith RL
    Clin Pharmacol Ther; 1979 Oct; 26(4):513-24. PubMed ID: 487699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of decursinol angelate on the pharmacokinetics of theophylline and its metabolites in rats.
    Chae JW; An JH; Kang W; Ma Jy; Kwon KI
    Food Chem Toxicol; 2012 Oct; 50(10):3666-72. PubMed ID: 22771369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Theophylline metabolism in human liver microsomes: inhibition studies.
    Tjia JF; Colbert J; Back DJ
    J Pharmacol Exp Ther; 1996 Mar; 276(3):912-7. PubMed ID: 8786569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Quantitative analysis of theophylline and its metabolites in urine of Chinese healthy subjects after oral administration of theophylline sustained-release tablets].
    Liu Y; Zhan Y; Zhang YF; Chen XY; Zhong DF
    Yao Xue Xue Bao; 2014 Jul; 49(7):1039-43. PubMed ID: 25233637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal clearance of theophylline and its major metabolites: age and urine flow dependency in paediatric patients.
    Bonnacker I; Berdel D; Süverkrüp R; von Berg A
    Eur J Clin Pharmacol; 1989; 36(2):145-50. PubMed ID: 2721539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Theophylline steady state pharmacokinetics is not altered by omeprazole.
    Taburet AM; Geneve J; Bocquentin M; Simoneau G; Caulin C; Singlas E
    Eur J Clin Pharmacol; 1992; 42(3):343-5. PubMed ID: 1577056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of theophylline: a dose-range study.
    Rovei V; Chanoine F; Strolin Benedetti M
    Br J Clin Pharmacol; 1982 Dec; 14(6):769-78. PubMed ID: 7150456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of fluconazole on theophylline disposition in humans.
    Konishi H; Morita K; Yamaji A
    Eur J Clin Pharmacol; 1994; 46(4):309-12. PubMed ID: 7957514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of lansoprazole on pharmacokinetics and metabolism of theophylline.
    Kokufu T; Ihara N; Sugioka N; Koyama H; Ohta T; Mori S; Nakajima K
    Eur J Clin Pharmacol; 1995; 48(5):391-5. PubMed ID: 8641328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of intravenous theophylline in mutant Nagase analbuminemic rats.
    Kim EJ; Suh OK; Lee MG
    Life Sci; 2003 Jan; 72(11):1231-45. PubMed ID: 12570924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonlinear renal excretion of theophylline and its metabolites, 1-methyluric acid and 1,3-dimethyluric acid, in rats.
    Kuh HJ; Shim CK
    Arch Pharm Res; 1994 Apr; 17(2):124-30. PubMed ID: 10319144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of mexiletine on elimination and metabolic conversion of theophylline and its major metabolites in rats.
    Ogiso T; Iwaki M; Tanino T; Okuyama K; Uno S
    Biol Pharm Bull; 1993 Feb; 16(2):163-7. PubMed ID: 8364452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of theophylline metabolite assays to the exploration of liver microsome oxidative function in man.
    Naline E; Sanceaume M; Pays M; Advenier C
    Fundam Clin Pharmacol; 1988; 2(4):341-51. PubMed ID: 3265407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of CYP inducers and inhibitors on the pharmacokinetics of intravenous theophylline in rats: involvement of CYP1A1/2 in the formation of 1,3-DMU.
    Yang KH; Lee JH; Lee MG
    J Pharm Pharmacol; 2008 Jan; 60(1):45-53. PubMed ID: 18088504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of enoxacin, ofloxacin and norfloxacin on theophylline disposition in humans.
    Sano M; Kawakatsu K; Ohkita C; Yamamoto I; Takeyama M; Yamashina H; Goto M
    Eur J Clin Pharmacol; 1988; 35(2):161-5. PubMed ID: 3191935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A metabolic and pharmacokinetic comparison of theophylline and aminophylline (theophylline ethylenediamine).
    Monks TJ; Smith RL; Caldwell J
    J Pharm Pharmacol; 1981 Feb; 33(2):93-7. PubMed ID: 6111606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.